If you are on Medicare and have been watching GLP-1 medications like Ozempic and Wegovy from a distance because of the cost — things just changed significantly.
As of July 1, 2026, the Centers for Medicare and Medicaid Services launched the GLP-1 Bridge program, making certain GLP-1 medications available to eligible Medicare beneficiaries for approximately $50 per month. That is a reduction of up to 95% from what some people were previously paying out of pocket.
Here is everything you need to know about what changed, who qualifies, and how to get started.
What is the GLP-1 Bridge program?
The GLP-1 Bridge is an 18-month pilot initiative introduced by CMS — the federal agency that runs Medicare — specifically to expand access to GLP-1 obesity medications for eligible Medicare beneficiaries. The program runs through December 31, 2027.
Before this program Medicare did not cover GLP-1 medications for weight loss. Coverage existed for GLP-1s prescribed for type 2 diabetes but not for obesity treatment specifically. The GLP-1 Bridge changes that — making these medications accessible to a much broader group of Medicare enrollees at a dramatically reduced cost.
Who qualifies for the Medicare GLP-1 Bridge program?
Eligibility for the GLP-1 Bridge program is based on several factors including your Medicare enrollment status, your BMI, and any related health conditions. Generally speaking you may be eligible if you are enrolled in Medicare Part D, have a BMI of 30 or higher or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, heart disease, or sleep apnea, and meet your plan's specific coverage criteria.
Because eligibility details vary by Medicare plan and individual health profile, the best way to find out if you qualify is to speak with a licensed provider who can review your specific situation.
How much will it cost?
Under the GLP-1 Bridge program eligible beneficiaries can access certain GLP-1 medications for approximately $50 per month. This compares to retail prices of $900 to $1,349 per month for brand-name medications like Wegovy without coverage — making this one of the most significant expansions of affordable weight loss care in recent memory.
Which medications are covered?
The specific medications covered under the GLP-1 Bridge program depend on your Medicare Part D plan formulary. Coverage may include brand-name GLP-1 medications approved for obesity treatment. Your licensed provider can help you understand which options are covered under your specific plan and what alternatives may be available if your preferred medication is not included.
What if I don't have Medicare — are there still affordable options?
Yes. Even if you are not on Medicare or do not qualify for the GLP-1 Bridge program there are still highly affordable options available through telehealth providers offering cash-pay GLP-1 treatment.
Compounded semaglutide — which contains the same active ingredient as Ozempic and Wegovy — is available through licensed telehealth providers for $99 to $350 per month without insurance. Newer oral GLP-1 options have also entered the market in 2026 starting at $149 per month.
America is Well connects people of all ages and insurance situations with trusted licensed providers who can walk you through every option available to you.
How do I get started?
Whether you are on Medicare or accessing GLP-1 treatment through a cash-pay telehealth provider the first step is the same — complete a free assessment so a licensed provider can review your health profile and confirm your eligibility.
America is Well makes this process simple. Complete our free 60-second assessment and a trusted licensed provider will reach out within 24 hours to walk you through your options — including whether you qualify under the Medicare GLP-1 Bridge program.
There is no cost to get matched, no obligation to continue, and your information is 100% confidential and protected by HIPAA — never shared, never sold.
Why this matters
For millions of older Americans who have struggled with weight-related health conditions for years — high blood pressure, joint pain, sleep apnea, heart disease — GLP-1 treatment has represented a potential turning point that was simply out of financial reach.
The GLP-1 Bridge program changes that. If you or someone you love is on Medicare and has been curious about GLP-1 treatment, now is the time to find out if you qualify.
The bottom line
Medicare now covers GLP-1 medications for eligible beneficiaries at approximately $50 per month — a massive shift from where things stood even six months ago. The GLP-1 Bridge program runs through December 2027 giving eligible enrollees an 18-month window to access this treatment at historically low cost.
The first step is finding out if you qualify. It takes 60 seconds and it is completely free.
America is Well is not a medical provider. We connect individuals with trusted, licensed, independent healthcare providers. This article is for informational purposes only and is not a substitute for professional medical advice. Medicare coverage details vary by plan — consult your plan provider or a licensed healthcare professional for information specific to your situation.
Find out if you qualify for GLP-1 treatment today.
It takes 60 seconds and it is completely free.
See If You Qualify →